Cargando…

Chloroquine and hydroxychloroquine as available weapons to fight COVID-19

Detalles Bibliográficos
Autores principales:	Colson, Philippe, Rolain, Jean-Marc, Lagier, Jean-Christophe, Brouqui, Philippe, Raoult, Didier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier B.V. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135139/ https://www.ncbi.nlm.nih.gov/pubmed/32145363 http://dx.doi.org/10.1016/j.ijantimicag.2020.105932

Ejemplares similares

Chloroquine for the 2019 novel coronavirus SARS-CoV-2
por: Colson, Philippe, et al.
Publicado: (2020)

New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
por: Devaux, Christian A., et al.
Publicado: (2020)

Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century
por: Rolain, Jean-Marc, et al.
Publicado: (2007)

Outcomes of 2111 COVID-19 Hospitalized Patients Treated with Hydroxychloroquine/Azithromycin and Other Regimens in Marseille, France, 2020: A Monocentric Retrospective Analysis
por: Lagier, Jean-Christophe, et al.
Publicado: (2022)

Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity
por: Hache, Guillaume, et al.
Publicado: (2021)

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited
por: Gautret, Philippe, et al.
Publicado: (2021)

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
por: Gautret, Philippe, et al.
Publicado: (2020)

Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients
por: Gautret, Philippe, et al.
Publicado: (2021)

Cardiovascular Safety of Hydroxychloroquine–Azithromycin in 424 COVID-19 Patients
por: Million, Matthieu, et al.
Publicado: (2023)

Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19
por: Gautret, Philippe, et al.
Publicado: (2021)

Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis
por: Lagier, Jean-Christophe, et al.
Publicado: (2020)

Low blood zinc concentrations in patients with poor clinical outcome during SARS-CoV-2 infection: is there a need to supplement with zinc COVID-19 patients?
por: Dubourg, Grégory, et al.
Publicado: (2021)

Response to effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial.
por: Gautret, Philippe, et al.
Publicado: (2021)

A new strategy to fight antimicrobial resistance: the revival of old antibiotics
por: Cassir, Nadim, et al.
Publicado: (2014)

Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin
por: Million, Matthieu, et al.
Publicado: (2021)

Interpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19
por: Colson, Philippe, et al.
Publicado: (2021)

Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes
por: Gautret, Philippe, et al.
Publicado: (2021)

Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
por: Gautret, Philippe, et al.
Publicado: (2021)

Asymptomatic hypoxia in COVID-19 is associated with poor outcome
por: Brouqui, Philippe, et al.
Publicado: (2021)

Evaluation of Strategies to Fight COVID-19: The French Paradigm
por: Giraud-Gatineau, Audrey, et al.
Publicado: (2021)

Fighting viruses with antibiotics: an overlooked path
por: Colson, Philippe, et al.
Publicado: (2016)

Teicoplanin: an alternative drug for the treatment of COVID-19?
por: Baron, Sophie Alexandra, et al.
Publicado: (2020)

Re: ‘Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients’ by Fiolet et al.
por: Million, Matthieu, et al.
Publicado: (2021)

Clinical efficacy of chloroquine derivatives in COVID-19 infection: comparative meta-analysis between the big data and the real world
por: Million, M., et al.
Publicado: (2020)

SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment
por: Drancourt, Michel, et al.
Publicado: (2021)

Outcomes after early treatment with hydroxychloroquine and azithromycin: An analysis of a database of 30,423 COVID-19 patients
por: Brouqui, Philippe, et al.
Publicado: (2023)

Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load.
por: Gautret, Philippe, et al.
Publicado: (2021)

Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
por: Gautret, Philippe, et al.
Publicado: (2020)

Does spitting in public play a role in transmitting SARS-CoV-2?
por: Gautret, Philippe, et al.
Publicado: (2020)

Chloroquine, hydroxychloroquine and COVID-19
por: Erickson, T. B., et al.
Publicado: (2020)

Distinguishing Body Lice from Head Lice by Multiplex Real-Time PCR Analysis of the Phum_PHUM540560 Gene
por: Drali, Rezak, et al.
Publicado: (2013)

Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France
por: Million, Matthieu, et al.
Publicado: (2020)

WITHDRAWN: Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients
por: Million, Matthieu, et al.
Publicado: (2021)

Rickettsia slovaca and R. raoultii in Tick-borne Rickettsioses
por: Parola, Philippe, et al.
Publicado: (2009)

A Possible Role of Remdesivir and Plasma Therapy in the Selective Sweep and Emergence of New SARS-CoV-2 Variants
por: Colson, Philippe, et al.
Publicado: (2021)

In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect
por: Andreani, Julien, et al.
Publicado: (2020)

Evidence of SARS-CoV-2 re-infection with a different genotype
por: Colson, Philippe, et al.
Publicado: (2021)

Chloroquine and hydroxychloroquine in the context of COVID-19
por: Shukla, Ashutosh M, et al.
Publicado: (2020)

Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
por: Principi, Nicola, et al.
Publicado: (2020)

Real-Time Microbiology Laboratory Surveillance System to Detect Abnormal Events and Emerging Infections, Marseille, France
por: Abat, Cédric, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8i17uknm7sqjb8bqdqpludfacb